Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Sep 29;178:113992. doi: 10.1016/j.addr.2021.113992

Table 9.

Examples of DDS based on encapsulation of cargoes into RBC.

Cargo Disease Principle Testing Phase
L-Asparaginase Acute lymphoblastic leukemia

Pancreatic cancer

Ulcerative Colitis
RBC are loaded with asparaginase to act as drug depot that increases enzyme half-life and reduces toxicity to host Phase 2

Phase 3

Phase 2
Phenylalanine ammonia lyase (PAL) Phenylketonuria RBC are modified to produce PAL, an enzyme that breaks down phenylalanine, with increased half life and reduced immune-mediated side effects Phase 1 (active, not recruiting)
Thymidine phosphorylase Mitochondrial neurogastrointestinal encephalomyopathy RBC are loaded with thymidine phosphorylase, replacing the enzyme missing in this autosomal recessive condition Phase 2
Adenosine deaminase ADA Progenitor cells are transduced with lentiviral vector- cDNA for human ADA Phase 2
Dexamethasone Ataxia telangectasia

Breast cancer
Delivery to host defense cells

*only non-enzyme drug*
Phase 3

Phase 3